Deferoxamine
Back to searchMolecule Structure
Scientific Name
Deferoxamine
Description of the Drug
Deferoxamine is a chelating agent used to treat iron or aluminum toxicity and some blood transfusion dependent anemias.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00746
http://www.drugbank.ca/drugs/DB00746
Brand Name(s)
Not Available
Company Owner(s)
Fresenius Kabi Usa Llc, West-Ward Pharmaceuticals International Ltd, Hospira Inc, Gland Pharma Ltd, Dr Reddys Laboratories Ltd, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Iron | METAL | CHELATING AGENT | CHEMBL2363058 |
Clinical Trial(s)
Unichem Links
Atlas | deferoxamine | DFO | |||||
SureChEMBL | SCHEMBL34571 | ||||||
PharmGKB | PA164746490 | ||||||
Human Metabolome Database | HMDB0014884 | ||||||
DrugBank | DB00746 | ||||||
PubChem: Thomson Pharma | 14788466 | ||||||
PubChem | 2973 | ||||||
Mcule | MCULE-3095507442 | ||||||
NMRShiftDB | 70000541 | ||||||
LINCS | LSM-6541 | ||||||
Nikkaji | J10.199K | ||||||
PDBe | KTY | ||||||
BindingDB | 47715 | ||||||
EPA CompTox Dashboard | DTXSID7022887 | ||||||
LipidMaps | LMFA08020169 | ||||||
DrugCentral | 792 | ||||||
Metabolights | MTBLC4356 | ||||||
Brenda | 4808 | 105891 | 49980 | 74729 | 105890 | 23293 | 217361 |
ChemicalBook | CB8506290 | ||||||
rxnorm | DESFERAL | DEFEROXAMINE MESYLATE | DEFEROXAMINE | ||||
PubChem: Drugs of the Future | 12014086 | ||||||
ChEBI | 4356 | ||||||
ZINC | ZINC000003830635 |